AstraZeneca Takes Out Antibiotic Firm Novexel, With Cash Back from Forest
This article was originally published in The Pink Sheet Daily
Executive Summary
AZ will pay up to $505 million and split antibiotic cocktail rights with Novexel partner Forest, which in turn will pay more than $200 million to AZ.